🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to investigate the safety and activity in the ...
Status
Completed
Location
Arensia Clinical Research Unit
Start Date
2019-08-14
Trial ID
NCT04073498
This randomized, double-blind, parallel group study compares the efficacy a...
Status
Completed
Location
Multiple Locations
Start Date
2010-09
Trial ID
NCT01194414
This study evaluated the safety and tolerability of a single dose of ALXN12...
Status
Completed
Location
Clinical Trial Site
Start Date
2016-08-19
Trial ID
NCT05288829
Treatments Being Tested
The purpose of this study is to investigate how teriparatide or zoledronic ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2009-07
Trial ID
NCT00927186
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of ustekinumab as mea...
Status
Completed
Location
Multiple Locations
Start Date
2015-10-15
Trial ID
NCT02349061
Treatments Being Tested
The purpose of the study is to evaluate efficacy of riliprubart compared to...
Status
Recruiting
Location
Alabama Neurology Associates- Site Number : 8400019
Start Date
2024-08-21
Trial ID
NCT06290141
Treatments Being Tested
The purpose of this randomized, double-blind, placebo-controlled study is t...
Status
Completed
Location
Southern Cancer Center
Start Date
2013-06
Trial ID
NCT01873703
Treatments Being Tested
Netherton Syndrome (NS) is a severe rare disease characterized by generaliz...
Status
Terminated
Location
Saint Louis Hospital
Start Date
2023-09-28
Trial ID
NCT05979831
A randomized, double-blind, placebo-controlled phase I clinical study evalu...
Status
Not Yet Recruiting
Location
Huashan Hospital
Start Date
2025-04
Trial ID
NCT06945445
This study will assess the safety, tolerability, and efficacy of ABBV-3373 ...
Status
Completed
Location
Rheum Assoc of North Alabama /ID# 213626
Start Date
2019-03-27
Trial ID
NCT03823391
Treatments Being Tested